Dashboard
Manage Tickers

KRONKronos Bio, Inc.

Nasdaq kronosbio.com


$ 1.03 $ 0.00 (0 %)    

Friday, 03-May-2024 14:50:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.67 $ 3.35 (0.77 %)
DIA $ 386.61 $ -0.13 (-0.03 %)
SPY $ 511.45 $ 0.92 (0.18 %)
TLT $ 89.84 $ -0.27 (-0.3 %)
GLD $ 212.82 $ -0.60 (-0.28 %)
$ 1.03
$ 1.03
$ 1.02 x 600
$ 1.05 x 100
$ 1.03 - $ 1.03
$ 0.73 - $ 2.29
198,216
na
59.48M
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-23-2021 12-31-2020 10-K
14 11-18-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

kronos-bio-to-present-clinical-update-on-phase-12-trial-of-kb-0742-at-the-2024-asco-annual-meeting
Kronos Bio To Present Clinical Update On P...
04/24/2024 20:41:34

Kronos Bio, Inc. (NASDAQ:KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that...

recap-kronos-bio-q4-earnings
Recap: Kronos Bio Q4 Earnings
03/21/2024 13:35:05

kronos-bio-q4-eps-043-beats-052-estimate-sales-229m-beat-152m-estimate-cash-balance-of-1750m
Kronos Bio Q4 EPS $(0.43) Beats $(0.52) Es...
03/21/2024 11:08:43

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.52) by...

kronos-bio-announces-21-reduction-in-workforce-restructuring-to-focus-resources-on-clinical-development-with-extended-cash-runway-into-the-second-half-of-2026
Kronos Bio Announces 21% Reduction In Work...
03/07/2024 21:28:29

Company to assess KB-0742 at planned new dose schedule in ongoing phase 1/2 study; topline data from expansion cohort at new do...

kronos-bio-amends-protocol-for-its-trial-of-kb-0742-says-moving-forward-the-company-is-pursuing-a-four-days-on-three-days-off-dosing-schedule-to-further-increase-patient-time-on-kb-0742-at-or-above-a-therapeutic-threshold
Kronos Bio Amends Protocol For Its Trial O...
03/05/2024 12:14:05

kronos-bio-eliminates-executive-officer-roles-including-chief-medical-officer-chief-scientific-officer-and-chief-operating-officer-and-general-counsel
Kronos Bio Eliminates Executive Officer Ro...
01/25/2024 13:18:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/23/2024 13:06:09

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

cancer-player-kronos-bio-to-stop-lanraplenib-combo-therapy-blood-cancer-study
Cancer Player Kronos Bio To Stop Lanraplen...
12/19/2023 18:47:28

Kronos Bio Inc (NASDAQ: KRON) says that after the review of data from the phase 1b portion of its phase 1b/2 trial of lanraplen...

piper-sandler-maintains-overweight-on-kronos-bio-lowers-price-target-to-6
Piper Sandler Maintains Overweight on Kron...
12/19/2023 13:20:25

Piper Sandler analyst Edward Tenthoff maintains Kronos Bio (NASDAQ:KRON) with a Overweight and lowers the price target from ...

uber-to-rally-over-13-here-are-10-top-analyst-forecasts-for-tuesday
Uber To Rally Over 13%? Here Are 10 Top An...
12/19/2023 12:30:23

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

hc-wainwright--co-maintains-buy-on-kronos-bio-lowers-price-target-to-25
HC Wainwright & Co. Maintains Buy on Krono...
12/19/2023 11:16:18

HC Wainwright & Co. analyst Robert Burns maintains Kronos Bio (NASDAQ:KRON) with a Buy and lowers the price target from ...

kronos-bio-says-phase-1b-portion-of-phase-1b2-lanraplenib-study-does-not-support-continuing-to-phase-2
Kronos Bio Says Phase 1b Portion Of Phase ...
12/18/2023 21:08:05

hc-wainwright--co-reiterates-buy-on-kronos-bio-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Kron...
11/27/2023 11:44:28

HC Wainwright & Co. analyst Robert Burns reiterates Kronos Bio (NASDAQ:KRON) with a Buy and maintains $9 price target.

why-renew-energy-global-shares-are-trading-higher-by-around-14-here-are-other-stocks-moving-in-mondays-mid-day-session
Why ReNew Energy Global Shares Are Trading...
11/20/2023 19:35:58

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy ...

why-applied-uv-shares-are-trading-higher-by-around-96-here-are-20-stocks-moving-premarket
Why Applied UV Shares Are Trading Higher B...
11/20/2023 13:19:26

Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/20/2023 13:06:36

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/16/2023 21:31:07

kronos-bio-q3-eps-054-misses-051-estimate-sales-91700k-miss-140m-estimate
Kronos Bio Q3 EPS $(0.54) Misses $(0.51) E...
11/13/2023 22:22:44

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
11/13/2023 21:31:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION